Approved for use through 12/2005 under the following conditions: 1) no later than 6/2004, SAMHSA: a) submits to OMB a report summarizing incentive payments made to facilities by category (e.g. access,"critical" enhancements, piece rates, and performance incentives) and minimum to maximum ranges by facility: and b) SAMHSA briefs OMB at two appropriate "benchmark" dates on any issues arising from the DAWN redesign, including survey training, implementation experiences, ongoing quality controls, etc.; and 2) no later than 1/2003, SAMHSA once again evaluates the feasibility of linking significant data variables from past DAWN surveys to data collected under the DAWN redesign.
Inventory as of this Action
Requested
Previously Approved
12/31/2005
12/31/2005
12/31/2002
679,716
0
220,340
46,738
0
15,284
0
0
0
DAWN collects data on drug-related medical emergencies and deaths are reported from approximately 660 hospitals and medical examiners nationwide. Used by Federal, State, and local agencies, the ongoing data system supports efforts to identify drug abuse trends, assess heatlh hezards associated with substance abuse, and schedule substances under the Controlled Substances Act. This submission reflects a new sample design and revised reporting forms.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.